The event is captured by edwards lifesciences under complaint #: (b)(4).The manufacturer's investigation is ongoing.A follow-up report will be submitted when the manufacturer's investigation is complete.It should be noted, the device was implanted in the tricuspid position.At this time, the pascal precision transcatheter valve repair system is only indicated for the native mitral valve in the us, addressing degenerative mitral regurgitation.But, it is approved for both tricuspid and mitral spaces in the region where the procedure was performed.Therefore, deployment in the tricuspid position will not be considered off-label in this case.
|
Edwards received notification that on post-op day 521 after the cardioband procedure, the patient experienced worsening of tricuspid regurgitation (tr) and on post-op day 561 underwent tricuspid valve repair with pascal ace device.On post-op day 0 after the procedure with pascal ace, the patient had bradyarrhythmia absolute with breaks of over 2.5 seconds and symptomatology.Therefore, a pacemaker was implanted nine days after the pascal procedure.The outcome of the patient was reported as recovered.
|